A Case Report of Nongerminal Center B-Cell Type Diffuse Large B-Cell Lymphoma Treated to Complete Response with Rituximab and Ibrutinib

Figure 2

Staging imaging demonstrating response to treatment. (a) PET/CT imaging at initiation of treatment, after 2 cycles of treatment, 5 cycles of treatment, or 9 cycles of treatment as listed. (b) PET/CT imaging showing activity in the bone marrow and liver prior to treatment that was reduced to background levels after 9 cycles of treatment. White arrows indicate areas of active disease on the PET/CT.

(a)

(b)